For most people with bladder cancer, the first red flag is literally red: blood in the urine. But for people with color blindness, that warning sign may be easy to miss — and missing it could prove ...
The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the treatment of bladder cancer. The PD-1/antibody-drug conjugate pairing ...
Adenocarcinoma of the bladder is rare, originating from glandular cells, and can be primary or secondary, requiring accurate diagnosis for appropriate treatment. Diagnosis involves cystoscopy, biopsy, ...
Keytruda and Padcev combination shows improved event-free and overall survival in muscle invasive bladder cancer patients ineligible for cisplatin. The KEYNOTE-905/EV-303 trial demonstrated ...
All products and listings featured on Condé Nast Traveler are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these ...
NEW HAVEN, Conn. (WTNH) — The FDA recently approved the first breakthrough treatment for bladder cancer in 40 years. It comes at a time when Coach Prime – Deion Sanders – is sharing his bladder cancer ...
The FDA approved the Altaviva implantable nerve stimulator for urge urinary incontinence (UUI), a common symptom of overactive bladder (OAB), Medtronic announced. Inserted near the ankle in a ...
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results Clinical complete response (cCR) definition should encompass the ...
The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results